AR018824A1 - Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma - Google Patents

Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma

Info

Publication number
AR018824A1
AR018824A1 ARP990101485A ARP990101485A AR018824A1 AR 018824 A1 AR018824 A1 AR 018824A1 AR P990101485 A ARP990101485 A AR P990101485A AR P990101485 A ARP990101485 A AR P990101485A AR 018824 A1 AR018824 A1 AR 018824A1
Authority
AR
Argentina
Prior art keywords
glaucoma
treatment
control
bradiquinine
peptidic
Prior art date
Application number
ARP990101485A
Other languages
English (en)
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of AR018824A1 publication Critical patent/AR018824A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de una composicion que comprende un antagonista de bradiquinina no peptídica para la fabricacion de un medicamento para el ojo para el control depresion intraocular y/o para el tratamiento del glaucoma que comprende una composicion que incluye una cantidad terapéuticamente efectiva de unantagonista de bradiquina no peptídica en un vehículo farmacéuticamente aceptable. Las composiciones comprenden antagonistas no peptídicas debradiquinina.
ARP990101485A 1998-04-03 1999-03-31 Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma AR018824A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8073098P 1998-04-03 1998-04-03

Publications (1)

Publication Number Publication Date
AR018824A1 true AR018824A1 (es) 2001-12-12

Family

ID=22159253

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101485A AR018824A1 (es) 1998-04-03 1999-03-31 Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma

Country Status (4)

Country Link
US (1) US6500831B1 (es)
AR (1) AR018824A1 (es)
AU (1) AU2985399A (es)
WO (1) WO1999051235A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481855A1 (en) * 2002-04-10 2003-10-23 Ortho-Mcneil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
US7807629B1 (en) 2007-06-05 2010-10-05 Alcon Research, Ltd. Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
TW201210584A (en) 2010-08-18 2012-03-16 Alcon Res Ltd Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
CN103622961B (zh) * 2013-09-06 2016-03-02 武汉光谷百桥国际生物科技有限公司 一种非肽类缓激肽b2受体激动剂在促进毛发生长方面的应用
WO2016170382A1 (en) 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0529499A1 (de) * 1991-08-22 1993-03-03 Hoechst Aktiengesellschaft Pharmazeutische Zusammensetzungen enthaltend Bradykinin-Antagonisten zur lokalen Anwendung an Nase und Auge

Also Published As

Publication number Publication date
AU2985399A (en) 1999-10-25
US6500831B1 (en) 2002-12-31
WO1999051235A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
MXPA03008401A (es) Combinacion de brimonidina y timolol para uso oftalmico, topico.
TW200505402A (en) Ophthalmic drug delivery device
AU3056702A (en) Methods and compositions for treatment of ocular neovascularization and neural injury
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
BG106030A (en) Pharmaceutical composition
NO960630L (no) Heterocykler anvendelige som neurokinin antagonister
AU2002307049A1 (en) Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
MX9603259A (es) Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii.
ATE333896T1 (de) Vaskularisierungsinhibitoren
NO994823L (no) Benzocykloheptatiofenforbindelser
AR036199A1 (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
AR018824A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el control de la presion intraocular y en el tratamiento del glaucoma
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
DE69424033T2 (de) Pharmazeutische träger zur topischen ophthalmischen anwendung
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas
ATE342734T1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
BG107502A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
AU2502301A (en) Medicament and combination of compatible medicaments
PT942729E (pt) Utilizacao de antagonistas de receptores nk-1 para tratamento de doencas do stresse
NO981188D0 (no) 5-HT3-reseptorantagonister for dyskinesi